"renal cell cancer" trang 2 - tải miễn phí từ tailieunhanh
53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: A study based on TCGA and SEER database

53 years old is a reasonable cut-off value to define young and old patients in clear cell renal cell carcinoma: A study based on TCGA and SEER database
11    32    1
A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma

A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma
14    27    1
Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma

Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma
16    52    1
The mitochondrial fusion-associated protein MFN2 can be used as a novel prognostic molecule for clear cell renal cell carcinoma

The mitochondrial fusion-associated protein MFN2 can be used as a novel prognostic molecule for clear cell renal cell carcinoma
17    6    1
Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma

Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma
10    33    1
Kaempferol inhibits the invasion and migration of renal cancer cells through the downregulation of AKT and FAK pathways

Kaempferol inhibits the invasion and migration of renal cancer cells through the downregulation of AKT and FAK pathways
10    80    0
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK

Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK
9    93    1
Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion

Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion
12    70    0
Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan

Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan
7    68    1
Optimal sequencing of the first-and second-line target therapies in metastatic renal cell carcinoma: Based on nationally representative data analysis from the Korean National Health Insurance System

Optimal sequencing of the first-and second-line target therapies in metastatic renal cell carcinoma: Based on nationally representative data analysis from the Korean National Health Insurance System
13    6    1
Patients with metastatic renal cell carcinoma who receive immune-targeted therapy may derive survival benefit from nephrectomy

Patients with metastatic renal cell carcinoma who receive immune-targeted therapy may derive survival benefit from nephrectomy
10    6    1
Functional analysis of fatty acid binding protein 7 and its effect on fatty acid of renal cell carcinoma cell lines

Functional analysis of fatty acid binding protein 7 and its effect on fatty acid of renal cell carcinoma cell lines
8    101    1
HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma

HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma
15    71    1
Association between decreased ipsilateral renal function and aggressive behavior in renal cell carcinoma

Association between decreased ipsilateral renal function and aggressive behavior in renal cell carcinoma
7    1    1
The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions

The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions
6    84    0
Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: A prospective cohort study

Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: A prospective cohort study
9    45    1
Clinicopathologic features of TDO2 overexpression in renal cell carcinoma

Clinicopathologic features of TDO2 overexpression in renal cell carcinoma
11    26    1
The WIRE study a phase II, multi-arm, multicentre, non-randomised window-ofopportunity clinical trial platform using a Bayesian adaptive design for proof-ofmechanism of novel treatment strategies in operable renal cell cancer – a study protocol

The WIRE study a phase II, multi-arm, multicentre, non-randomised window-ofopportunity clinical trial platform using a Bayesian adaptive design for proof-ofmechanism of novel treatment strategies in operable renal cell cancer – a study protocol
11    75    1
Predominant global glomerulosclerosis in patients of upper urinary tract urothelial carcinoma with pre-existing renal function impairment is a predictor of poor renal outcomes

Predominant global glomerulosclerosis in patients of upper urinary tract urothelial carcinoma with pre-existing renal function impairment is a predictor of poor renal outcomes
10    68    1
Ιmpact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer

Ιmpact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer
7    60    0